Species differences of serum albumins: III. Analysis of structural characteristics and ligand binding properties during N-B transitions
- PMID: 9587956
- DOI: 10.1023/a:1011986028529
Species differences of serum albumins: III. Analysis of structural characteristics and ligand binding properties during N-B transitions
Abstract
Purpose: The aim of this study was to investigate the characteristics of the structural transitions and changes in ligand binding properties of different albumins during the pH-dependent structural transition, often referred to as the N-B transition.
Methods: Structural transitions were evaluated by means of spectrometry, differential scanning calorimetry and chemical modification. In addition, ligand binding properties were investigated using typical site-specific bound drugs (warfarin, phenylbutazone, ibuprofen and diazepam).
Results: Conformational changes, including N-B transition, clearly occurred in albumins from all species used in this study. The conformational stabilities of all the albumins were clearly lost in the weakly alkaline pH range. This was probably the result of the destruction of salt bridges between domain I and domain III in the albumin molecule. In addition, the profiles of the ANS-induced fluorescence were different and could be classified into two patterns, suggesting that hydrophobic pockets in the albumin molecules were different for the different species. The data suggest that the amino acid residues responsible for the transitions were some of the His residues located in domain I. Further, the ligand binding properties of the albumins were slightly different but statistically significant.
Conclusions: The overall mechanisms of the N-B transition may be similar for all the albumins, but its impact is considerably different among the species in terms of both structural characteristics and ligand binding properties. Furthermore, the transitions appear to be multi-step transitions.
Similar articles
-
Species differences of serum albumins: I. Drug binding sites.Pharm Res. 1997 Nov;14(11):1607-12. doi: 10.1023/a:1012138604016. Pharm Res. 1997. PMID: 9434282
-
A comparison of drug binding sites on mammalian albumins.Biochem Pharmacol. 1992 Sep 1;44(5):873-9. doi: 10.1016/0006-2952(92)90118-3. Biochem Pharmacol. 1992. PMID: 1382424
-
Species-dependent stereoselective drug binding to albumin: a circular dichroism study.Chirality. 2008 Mar;20(3-4):552-8. doi: 10.1002/chir.20521. Chirality. 2008. PMID: 18172833
-
Allostery in a monomeric protein: the case of human serum albumin.Biophys Chem. 2010 May;148(1-3):16-22. doi: 10.1016/j.bpc.2010.03.001. Epub 2010 Mar 6. Biophys Chem. 2010. PMID: 20346571 Review.
-
Serum Albumin, Lipid and Drug Binding.Subcell Biochem. 2020;94:383-397. doi: 10.1007/978-3-030-41769-7_15. Subcell Biochem. 2020. PMID: 32189308 Review.
Cited by
-
Reversible two-step unfolding of heme-human serum albumin: a (1)H-NMR relaxometric and circular dichroism study.J Biol Inorg Chem. 2009 Feb;14(2):209-17. doi: 10.1007/s00775-008-0439-7. Epub 2008 Oct 21. J Biol Inorg Chem. 2009. PMID: 18936983
-
Photoaffinity labeling of plasma proteins.Molecules. 2013 Nov 8;18(11):13831-59. doi: 10.3390/molecules181113831. Molecules. 2013. PMID: 24217326 Free PMC article. Review.
-
Protein-bound calcium phosphate in uremic rat serum: a quantitative study.J Biol Inorg Chem. 2020 Dec;25(8):1051-1063. doi: 10.1007/s00775-020-01807-x. Epub 2020 Aug 24. J Biol Inorg Chem. 2020. PMID: 32839886
-
Human Serum Albumin Aggregation/Fibrillation and its Abilities to Drugs Binding.Molecules. 2020 Jan 31;25(3):618. doi: 10.3390/molecules25030618. Molecules. 2020. PMID: 32023900 Free PMC article.
-
On quantitative relationships between drug-like compound lipophilicity and plasma free fraction in monkey and human.J Pharm Sci. 2012 Mar;101(3):1028-39. doi: 10.1002/jps.22822. Epub 2011 Dec 13. J Pharm Sci. 2012. PMID: 22170327 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources